Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Shares Outstanding (2018 - 2025)

Viemed Healthcare's Shares Outstanding history spans 8 years, with the latest figure at $38.0 million for Q4 2025.

  • For Q4 2025, Shares Outstanding fell 2.85% year-over-year to $38.0 million; the TTM value through Dec 2025 reached $38.0 million, down 2.85%, while the annual FY2025 figure was $38.0 million, 2.85% down from the prior year.
  • Shares Outstanding reached $38.0 million in Q4 2025 per VMD's latest filing, roughly flat from $38.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $39.6 million in Q4 2021 to a low of $38.0 million in Q3 2025.
  • Average Shares Outstanding over 5 years is $38.8 million, with a median of $38.8 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding: rose 2.83% in 2021, then dropped 4.01% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $39.6 million in 2021, then fell by 4.01% to $38.0 million in 2022, then increased by 1.2% to $38.5 million in 2023, then increased by 1.63% to $39.1 million in 2024, then dropped by 2.85% to $38.0 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Shares Outstanding are $38.0 million (Q4 2025), $38.0 million (Q3 2025), and $39.6 million (Q2 2025).